“TUDCA as a Therapy for Ulcerative Colitis (UC)”
This is a Phase I open label study examining the efficacy and safety of TUDCA (tauroursodeoxycholic acid) in ulcerative colitis treatment.
Drug - Tauroursoursodeoxycholic acid, brand name Tudcabil
Dosed in capsules containing 250 or 500mg of TUDCA for a total dose of 1.75-2g/day
A Phase I Open Label Study of the Efficacy and Safety of Tudca in Ulcerative Colitis